LoQus23
LoQus23 is a small molecule drugs developer for Huntington's disease founded in 2019 by David Reynolds.
Company Operating Status
Active
Country
Crunchbase URL
Founded Date
2019
Full Address
Building 522 Babraham Research Campus Cambridge CB22 3AT, UK
0
Industry
Latest Funding Round Date
October 2, 2024
Latest Funding Round Amount (USD)
43,000,000
Latest Funding Type
LinkedIn URL
Number of Employees (Ranges)
1 – 10
Pitchbook URL
Total Funding Amount (USD)
52,300,000
Official Website
Find more companies like LoQus23
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.